Spotlight on Rare Disease Clinical Development
There is a lot of uncertainty in the world right now, but one thing for certain is that rare disease and orphan indication clinical research…
Rare Disease Spotlight: Acromegaly
Learn more about acromegaly and our capabilities for clinical trials.
Rare Disease Webinar Series: Watch Now
Medpace gathered experts in all areas of rare disease clinical research and created a three part webinar series. All three parts are now on-demand and…
2020 Rare Disease Webinar Series – Reserve Your Spot
In this three-part series of discussions with top experts in clinical development for rare disease and orphan indications, Medpace, along with industry partners, will address…
How Medpace is Raising Awareness for Rare Disease Day 2019
We are delighted to announce our participation in Rare Disease Day for another consecutive year. In addition to our internal activities, Medpace will be hosting…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 2
In our previous post, we discussed how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate rare disease clinical research. Yet, as…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 1
A few months ago, Medpace and the Cincinnati Children’s Hospital Medical Center presented a webinar on the importance of patient-centric clinical research. Over the next…
Novel Approaches to Confirming CNS Penetration and Target Engagement
Richard Scheyer, MD, Vice President, Medical Affairs at Medpace answers some questions about his upcoming presentation about CNS-targeted therapies at DIA 2018.
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3
In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients…
How to Identify, Enroll, and Retain Rare Disease Populations in Clinical Trials
Enrolling enough subjects into a rare disease study can seem like an insurmountable challenge, especially when you're looking at a subset of a rare disease,…